Characterization of digital camera-based UV illumination fluorescent imaging for concentration measurement with limit of detection, specificity and precision
Bettina Fazekas, Dorina Gréta Pogány, Dorián László Galata, Zsombor Kristóf Nagy, Lilla Alexandra Mészáros, Edit Hirsch
{"title":"Characterization of digital camera-based UV illumination fluorescent imaging for concentration measurement with limit of detection, specificity and precision","authors":"Bettina Fazekas, Dorina Gréta Pogány, Dorián László Galata, Zsombor Kristóf Nagy, Lilla Alexandra Mészáros, Edit Hirsch","doi":"10.1016/j.ejps.2025.107117","DOIUrl":null,"url":null,"abstract":"<div><div>Nowadays the increased need for pharmaceutics requires fast, cheap and reliable quality control systems to investigate the final product’s quality. The generally used methods like high-pressure liquid chromatography (HPLC) and other coupled techniques are not just time-consuming but also expensive and often destructive. To facilitate real-time measurement of active ingredient concentration, an alternative non-destructive machine vision and artificial intelligence-based system was tested, that implements ultraviolet (UV) illumination. With this technique the concentration of the active pharmaceutical ingredient containing fluorophore groups can be studied due to the different light emission of the different active pharmaceutical ingredient concentrations. However, to facilitate the practical application of this novel non-destructive and system, it is essential to determine its limit of detection (LoD) and limit of quantification (LoQ). In this study we aimed to study the LoD and LoQ of UV illumination fluorescent imaging of tablets using levofloxacin as the active pharmaceutical ingredient. We also execute intermediate precision and specificity studies to gather more information about the reliability of this novel technique.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"210 ","pages":"Article 107117"},"PeriodicalIF":4.3000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928098725001162","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Nowadays the increased need for pharmaceutics requires fast, cheap and reliable quality control systems to investigate the final product’s quality. The generally used methods like high-pressure liquid chromatography (HPLC) and other coupled techniques are not just time-consuming but also expensive and often destructive. To facilitate real-time measurement of active ingredient concentration, an alternative non-destructive machine vision and artificial intelligence-based system was tested, that implements ultraviolet (UV) illumination. With this technique the concentration of the active pharmaceutical ingredient containing fluorophore groups can be studied due to the different light emission of the different active pharmaceutical ingredient concentrations. However, to facilitate the practical application of this novel non-destructive and system, it is essential to determine its limit of detection (LoD) and limit of quantification (LoQ). In this study we aimed to study the LoD and LoQ of UV illumination fluorescent imaging of tablets using levofloxacin as the active pharmaceutical ingredient. We also execute intermediate precision and specificity studies to gather more information about the reliability of this novel technique.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.